Literature DB >> 20949601

Association of microtia with maternal obesity and periconceptional folic acid use.

Chen Ma1, Suzan L Carmichael, Angela E Scheuerle, Mark A Canfield, Gary M Shaw.   

Abstract

The study objective was to examine the association of microtia with maternal intake of folic-acid-containing supplements and obesity. The study data included deliveries from 1997 to 2005 from the National Birth Defects Prevention Study. Non-syndromic cases of microtia were compared to non-malformed, population-based liveborn control infants, by estimating adjusted odds ratios (AORs) and 95% confidence intervals (CIs) from logistic regression models that included maternal race/ethnicity, education, and study site. Maternal obesity was only weakly associated with microtia. Maternal periconceptional intake of folic-acid-containing vitamin supplements reduced the risk for microtia, but only among non-obese women (OR: 0.63; 95% CI: 0.44-0.91). The reduced risk was stronger when analyses were restricted to isolated cases (OR: 0.51; 95% CI: 0.34-0.77), and it was independent of the level of maternal dietary folate intake. Adjusting for maternal race/ethnicity did not reveal alternative interpretations of this association. This analysis suggests that maternal periconceptional intake of folic-acid-containing supplements may provide protection from microtia for non-obese women.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20949601     DOI: 10.1002/ajmg.a.33694

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

1.  Evaluation of prenatal diabetes mellitus and other risk factors for craniofacial microsomia.

Authors:  Babette Siebold; Carrie L Heike; Brian G Leroux; Matthew L Speltz; Amelia F Drake; Alexis L Johns; Kathleen A Kapp-Simon; Leanne Magee; Daniela V Luquetti
Journal:  Birth Defects Res       Date:  2019-03-30       Impact factor: 2.344

2.  Sociodemographic, health behavioral, and clinical risk factors for anotia/microtia in a population-based case-control study.

Authors:  Marisa A Ryan; Andrew F Olshan; Mark A Canfield; Adrienne T Hoyt; Angela E Scheuerle; Suzan L Carmichael; Gary M Shaw; Martha M Werler; Sarah C Fisher; Tania A Desrosiers
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2019-03-23       Impact factor: 1.675

3.  Vasoactive exposures during pregnancy and risk of microtia.

Authors:  Carla M Van Bennekom; Allen A Mitchell; Cynthia A Moore; Martha M Werler
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2012-11-24

4.  Impact of obesity on ovotoxicity induced by 7,12-dimethylbenz[a]anthracene in mice.

Authors:  Jackson Nteeba; Shanthi Ganesan; Aileen F Keating
Journal:  Biol Reprod       Date:  2014-03-27       Impact factor: 4.285

Review 5.  Microtia: epidemiology and genetics.

Authors:  Daniela V Luquetti; Carrie L Heike; Anne V Hing; Michael L Cunningham; Timothy C Cox
Journal:  Am J Med Genet A       Date:  2011-11-21       Impact factor: 2.802

6.  Microtia-anotia: a global review of prevalence rates.

Authors:  Daniela Varela Luquetti; Emanuele Leoncini; Pierpaolo Mastroiacovo
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-06-07

7.  Maternal exposures in the National Birth Defects Prevention Study: Time trends of selected exposures.

Authors:  April L Dawson; Hilda Razzaghi; Annelise Arth; Mark A Canfield; Samantha E Parker; Jennita Reefhuis
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2015-04-17

8.  Sociodemographic and hispanic acculturation factors and isolated anotia/microtia.

Authors:  Adrienne T Hoyt; Mark A Canfield; Gary M Shaw; Dorothy K Waller; Kara N D Polen; Tunu Ramadhani; Marlene T Anderka; Angela E Scheuerle
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-07-30

Review 9.  The impact of folic acid supplementation on gestational and long term health: Critical temporal windows, benefits and risks.

Authors:  Carla Silva; Elisa Keating; Elisabete Pinto
Journal:  Porto Biomed J       Date:  2017-07-12

Review 10.  [Hearing rehabilitation with the Vibrant Soundbridge in patients with congenital middle ear malformation].

Authors:  J M Hempel; A Epp; V Volgger
Journal:  HNO       Date:  2021-02-18       Impact factor: 1.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.